Pamicell, Top Search Ranking... Stock Price -2.02%

Pamisell has ranked among the top searched stocks on 6 days within the past month.

As of 2:34 PM on the 4th, Pamisell is trading at 16,950 KRW, down 2.02% from the previous day. This represents a 22.43% decrease compared to December 3rd. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net sellers of 63,000 shares. Over the past 5 days, individual investors have net sold 176,291 shares, while foreigners and institutions have net bought 144,120 shares and 14,853 shares, respectively.

On December 28th, Pamisell was a market issue due to a decline amid suspicions of 'unauthorized freezing' of stem cell therapy products.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.